Hyperpigmentation, melasma, and dark spots on the skin can be frustrating and difficult to resolve when relying on ineffective over the counter bleaching products or facial treatments at a medical spa
As demand expands, were also seeing growing potential for off-label useunderscoring the need for thoughtful clinical oversight, clear coverage policies, and a balanced approach to cost management. Understanding the Coverage Landscape As GLP-1 medications have demonstrated meaningful weight loss outcomes, their use beyond diabetes treatment has grown significantly
PlexusDx offers compounded semaglutide and tirzepatide injectables and oral forms from licensed 503A pharmacies, at $189/mo month-to-month, or from $149/mo on the 6-month plan
Using propensity matching, the researchers compared 2,894 patients taking a GLP-1 receptor agonist at baseline with 2,894 patients not taking one at baseline